U.S. Government Turns To British Firm To Develop Ebola Vaccine

"Underfunded U.S. Scientists Give Up, Turn To Europe"
http://www.care2.com/causes/some-underfunded-u-s-scientists-give-up-research-abroad-instead.html

***

"When U.S. Scientists Give Up"
NPR
http://www.npr.org/blogs/health/2014/09/09/345289127/when-scientists-give-up?refresh=true

***

"The first human trial of an Ebola vaccine has so far produced no adverse effects, according to...Anthony Fauci, director of the NIH's Institute of Allergy and Infectious Diseases....The Phase I trial is being conducted at an NIH facility in Bethesda, Md. and is focused on building scientific evidence that the vaccine is safe in humans. It was developed by British drug-maker GlaxoSmithKline in conjunction with the NIH." Abby Phillip in The Washington Post.